These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 327556)

  • 21. Criticism of tumor response criteria raises trial design questions.
    Twombly R
    J Natl Cancer Inst; 2006 Feb; 98(4):232-4. PubMed ID: 16478740
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug trials in pediatric oncology: a multi-facetted problem.
    Boos J
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):613-20. PubMed ID: 9849753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dying for a cure. Why cancer patients often turn to risky, experimental treatments--and wind up paying with their lives.
    Kaplan S; Brownlee S
    US News World Rep; 1999 Oct; 127(14):34-7, 40-3. PubMed ID: 10621514
    [No Abstract]   [Full Text] [Related]  

  • 24. Two-stage plans for patient accrual in phase II cancer clinical trials.
    Lee YJ; Staquet M; Simon R; Catane R; Muggia F
    Cancer Treat Rep; 1979; 63(11-12):1721-6. PubMed ID: 526910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer clinical trials: development and implementation.
    Vail DM
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1033-57; v. PubMed ID: 17950881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethics and errors of clinical trials and the role and place of different types of trial.
    Mathé G; Reizenstein P
    Drugs Exp Clin Res; 1986; 12(1-3):1-9. PubMed ID: 3732046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applicability of phase I trial results in the design of phase II and III biological response modifier trials.
    Pinsky CM
    Cancer Treat Rep; 1985 Oct; 69(10):1171-3. PubMed ID: 4042095
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II clinical trials.
    Carter SK; Selawry O
    Natl Cancer Inst Monogr; 1977 Mar; (45):81-92. PubMed ID: 337157
    [No Abstract]   [Full Text] [Related]  

  • 30. A nurse's understanding of trials in oncology.
    Monahan ML; Seymour SF
    Fla Nurse; 1986; 34(10):19. PubMed ID: 3641758
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase I cancer trials: limitations and implications.
    Dillman RO; Koziol JA
    Mol Biother; 1992 Sep; 4(3):117-21. PubMed ID: 1445664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled studies in clinical cancer research.
    Chalmers TC; Block JB; Lee S
    N Engl J Med; 1972 Jul; 287(2):75-8. PubMed ID: 4555591
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer chemotherapy: the primary physician's role.
    Lloyd RE
    Ariz Med; 1976 May; 33(5):381-4. PubMed ID: 776142
    [No Abstract]   [Full Text] [Related]  

  • 34. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phased clinical trials in cancer chemotherapy].
    Yokoyama M
    Gan No Rinsho; 1983 Aug; 29(10):1205-16. PubMed ID: 6355555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment designs: efficiency in development of cancer treatments.
    Temple RJ
    J Clin Oncol; 2005 Aug; 23(22):4838-9. PubMed ID: 15983397
    [No Abstract]   [Full Text] [Related]  

  • 37. How large should a phase II trial of a new drug be?
    Simon R
    Cancer Treat Rep; 1987 Nov; 71(11):1079-85. PubMed ID: 3315196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer research program strategy and planning--the use of contracts for program implementation.
    Baker CG
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):651-69. PubMed ID: 328910
    [No Abstract]   [Full Text] [Related]  

  • 39. Papers presented at a symposium on cancer chemotherapy in the 1980's. Monte Carlo, 11th-12th October, 1984.
    Invest New Drugs; 1985; 3(2):79-222. PubMed ID: 3894281
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II trials: use of a clinical tumor panel and overview of current resources and studies.
    Muggia FM; Rozencweig M; Chiuten DF; Jensen-Akula MS; Charles LM; Kubota TT; Bono VH
    Cancer Treat Rep; 1980 Jan; 64(1):1-9. PubMed ID: 6991100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.